American Century Companies’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,660
| Closed | -$41K | – | 2884 |
|
|
2024
Q3 | $41K | Sell |
10,660
-7,826
| -42% | -$30.1K | ﹤0.01% | 2870 |
|
|
2024
Q2 | $57.1K | Sell |
18,486
-107,728
| -85% | -$333K | ﹤0.01% | 2855 |
|
|
2024
Q1 | $326K | Buy |
126,214
+43,814
| +53% | +$113K | ﹤0.01% | 2612 |
|
|
2023
Q4 | $206K | Buy |
82,400
+64,627
| +364% | +$162K | ﹤0.01% | 2682 |
|
|
2023
Q3 | $36.1K | Buy |
17,773
+7,113
| +67% | +$14.4K | ﹤0.01% | 2822 |
|
|
2023
Q2 | $24.5K | Buy |
+10,660
| New | +$24.5K | ﹤0.01% | 2781 |
|
|
2018
Q3 | – | Sell |
-11,121
| Closed | -$81K | – | 1252 |
|
|
2018
Q2 | $81K | Buy |
+11,121
| New | +$81K | ﹤0.01% | 1278 |
|